Does a long half-life mean a substance works better?

Not automatically. A long half-life provides more even levels and less frequent administration, but it also means that, in the event of problems or side effects, the substance stays in the body correspondingly long. Whether long or short is more favorable depends on the purpose - that is a medical judgment.

Does the half-life tell you how long the effect lasts?

Only approximately. What is usually measured is the plasma half-life (detectability in the blood). The actual duration of effect can be longer if a substance binds tightly to its receptor or triggers downstream effects.

Why does semaglutide have such a much longer half-life than natural GLP-1?

Semaglutide is deliberately modified so that it binds more than 99 % to the blood protein albumin and is broken down and excreted more slowly. This raises the half-life from around two minutes (native GLP-1) to about one week - with the same receptor.

Pharmacology Basics8 min readLast reviewed: June 2026

Understanding half-life: t½, steady state, and why peptides act over such different timescales

"Half-life" is one of the most frequently used and at the same time most misunderstood terms when it comes to compounds and peptides. It describes how quickly the body gets rid of a substance again - and explains why some substances are studied several times a day and others only once a week. This article explains the concept in a beginner-friendly way: what t½ exactly means, why after four to five half-lives practically nothing is left, how a balance (steady state) is reached with repeated administration - and why peptides range from a few minutes to several days. Important up front: this is purely a knowledge foundation. We name no dosages and give no usage recommendations.

Machine-assisted translation. The German original is the authoritative version.

Key points

The half-life (t½) is the time until half of a substance has disappeared from the blood; the decline is exponential (a fixed proportion per unit of time).
After four to five half-lives around 94-97 % has been eliminated - and it takes just as long to reach steady state with repeated administration.
Plasma and effect half-life can diverge: the effect can outlast the measurable blood levels.
Peptides range from minutes (native) to days (engineered) - albumin binding, lipidation, PEGylation, or Fc-fusion prolong them.
This article only explains the concept; it deliberately contains no dosages, intervals, or usage recommendations.

What the half-life (t½) means

The elimination half-life (t½ for short) is the time in which the concentration of a substance in the blood falls to half its initial value. Most compounds follow first-order kinetics: in each time interval, not a fixed amount but a fixed proportion is removed. As a result, the decline is exponential - fast at first, then ever slower.

The half-life depends on two quantities: how quickly the body clears the substance (clearance, primarily via the kidney and liver) and how widely the substance distributes into tissue (volume of distribution). Simplified: t½ ≈ 0.693 × volume of distribution / clearance. This is not a calculation recipe for an application, but it explains why the same substance stays in the body longer when kidney or liver function is impaired.

t½ = time until the concentration in the blood falls to half.
First-order kinetics: each half-life removes a fixed proportion, not a fixed amount.
Determined by clearance (kidney/liver) and volume of distribution.
Impaired organ function prolongs the half-life.

The four-to-five-half-lives rule of thumb

From first-order kinetics follows a useful rule of thumb. After each half-life, half of the previous amount remains: after one t½ still 50 %, after two 25 %, after three 12.5 %, after four around 6 %, after five around 3 %. In other words, after four to five half-lives about 94-97 % has been eliminated - the substance is practically "out".

This rule works in both directions. If a substance is administered repeatedly, it likewise takes about four to five half-lives until a stable balance (steady state) is reached. A substance with a short half-life reaches this balance quickly, one with a long half-life correspondingly slowly.

Remaining: 50 → 25 → 12.5 → ~6 → ~3 % after 1 to 5 half-lives.
After 4-5 t½ around 94-97 % is eliminated (practically complete).
Symmetrical: steady state is likewise reached after ~4-5 t½.

Steady state and accumulation with repeated administration

With a single administration, the concentration rises and then falls. With regular repetition, what matters is how the time interval relates to the half-life. If the gap between administrations is shorter than the half-life, a remainder is still present at the next time - the substance accumulates until intake and elimination balance out. This plateau is the steady state.

In pharmacology, a conceptual distinction is made between an initial "push" that rapidly fills the volume of distribution and an ongoing contribution that thereafter only offsets the elimination. This explains why some compounds only show their full, even effect after days or weeks. We deliberately do not name concrete amounts or intervals here - that is a matter for medical management.

Interval shorter than t½ → accumulation until balance (steady state).
The degree of accumulation depends on the ratio of interval ↔ half-life.
Substances with a long t½ take longer to reach the full, even effect.
No dosage or interval figures - that belongs in medical hands.

Plasma half-life is not the same as effect half-life

A common misconception is that the half-life directly tells you how long the effect lasts. What is usually measured is the plasma half-life - that is, how long the substance is detectable in the blood. The biological or effect half-life can differ from this: effects can outlast the measurable blood levels, for instance because a substance binds tightly to its receptor or downstream signaling pathways remain active longer.

A good example is the body's own gut hormone GLP-1: its plasma half-life is only about two minutes, because it is rapidly broken down by the enzyme DPP-4 - yet its physiological effects last longer. The short plasma figure therefore does not mirror the effect one to one.

Plasma half-life is not the same as duration of effect.
The effect can outlast the blood levels (receptor binding, signaling cascades).
Example: native GLP-1 is only ~2 minutes in the blood but acts longer.

Why peptides range from minutes to days

With peptides in particular, the range is enormous. Many natural peptides are broken down within minutes by enzymes (peptidases). Modern, deliberately modified peptides, by contrast, last for days. The difference arises from structural modifications that slow degradation and slow elimination via the kidney: binding to the blood protein albumin, attaching a fatty-acid chain (lipidation), PEGylation, or fusion with an antibody fragment (Fc).

The most striking example is semaglutide: it acts at the same receptor as natural GLP-1, but is modified so that it binds more than 99 % to albumin. Its half-life is around one week - after the last administration it remains detectable in the circulation for about five weeks. Roughly two minutes thus become about seven days, through molecular design alone.

Native peptides: often minutes (rapid peptidase degradation).
Engineered peptides: up to days - via albumin binding, lipidation, PEGylation, Fc-fusion.
Semaglutide: t½ ~1 week, more than 99 % albumin-bound (vs. ~2 minutes for native GLP-1).
Same receptor, a thousandfold difference - through structural change alone.

Related substance profiles

Semaglutid

GLP-1 receptor agonist — approved, prescription-only.

Liraglutid

Approved, prescription-only GLP-1 receptor agonist for type 2 diabetes and obesity – a predecessor of semaglutide and not a substance for self-administration.

Tirzepatid

Dual GIP/GLP-1 receptor agonist — approved, prescription-only.

Frequently asked questions

Does a long half-life mean a substance works better?: Not automatically. A long half-life provides more even levels and less frequent administration, but it also means that, in the event of problems or side effects, the substance stays in the body correspondingly long. Whether long or short is more favorable depends on the purpose - that is a medical judgment.
Does the half-life tell you how long the effect lasts?: Only approximately. What is usually measured is the plasma half-life (detectability in the blood). The actual duration of effect can be longer if a substance binds tightly to its receptor or triggers downstream effects.
Why does semaglutide have such a much longer half-life than natural GLP-1?: Semaglutide is deliberately modified so that it binds more than 99 % to the blood protein albumin and is broken down and excreted more slowly. This raises the half-life from around two minutes (native GLP-1) to about one week - with the same receptor.

Sources

This article is for information and education only. It does not replace medical advice and deliberately contains no dosing, usage or sourcing information.

← All guide articles